human GALNT6 Adenovirus
This is an Adenovirus expressing Human GALNT6.
ADV-209600
Ad-h-GALNT6
Ready-to-use Adenovirus expressing Human GALNT6 (polypeptide N-acetylgalactosaminyltransferase 6). Available with optional GFP reporter or cell-specific promoter.
Gene Reference Data
Alternate Names
GALNAC-T6; GalNAcT6
Description (Vector)
GALNT6 encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. The encoded protein is capable of glycosylating fibronectin peptide in vitro and is expressed in a fibroblast cell line, indicating that it may be involved in the synthesis of oncofetal fibronectin.
Gene ID
11226
Gene Name (Vector)
polypeptide N-acetylgalactosaminyltransferase 6
Gene Symbol
GALNT6
HGNC ID
HGNC:4128
ORF Size (aa)
1869
ORF Size (bp)
1869 bp
RefSeq ID
NM_007210
RefSeq Synonyms
NM_007210, BC114505, BC035822,
Species
human
UniGene ID
Hs.505575
Recently Viewed Products
Ad-CMV-Luc
Cat No: 1000
Ad-CMV-Akt1 (Myr)
Cat No: 1020
Ad-CMV-Akt1 (dn)
Cat No: 1021
Ad-CMV-Akt1 (wt)
Cat No: 1022
About Storage Conditions
All our viral products should be kept at -80°C. At this temperature, the virus will remain stable for 6-12 months (and in some cases, up to 2 years). Once thawed, the product can be stored at 4°C for 2-3 weeks without significant loss of biological activity.
We recommend aliquoting your vectors into low protein binding tubes upon receipt. This helps avoid repeated freeze-thaw cycles, as well as prevent loss of virus. To maintain accurate titer, aliquot in at least 20ul per tube.

